Having operated in the filtration market for over 30 years, Croft Filters has provided various filter designs to wastewater treatment plants.
Filtration plays a vital part in the pharmaceutical manufacturing process. It can have a critical impact on the quality of the products. To enhance R&D results, pharmaceutical filtration systems can also be improved with the help of filtration specialists, such as Croft Filters.
A recent research study by Acumen Research and Consulting shows that the global pharmaceutical manufacturing market is expected to grow at a CAGR of around 15.9% between 2020 and 2027. One of the key market drivers being the increasing investment in pharmaceutical R&D.
Aside from internal factors within the pharma market, external factors, including COVID-19 and Brexit to UK manufacturers, can also shape the way drug manufacturers operate. Pharma Manufacturing reveals some of the top trends determined by experts that will impact the pharma industry. With small scale manufacturing set to grow and capacities expanding, our pharmaceutical filtration solutions are the ideal choice for organisations of any size or scale.
The continuous shift towards niche medicine within the pharmaceutical industry and the growth of small-scale manufacturing
The way new drugs are being developed is predicted to be changed judging from niche product indications and how CDMOs work with partners. Instead of mass-producing blockbuster drugs, CDMOs will continue to move to manufacture new pharmaceutical products at a smaller scale. There are other factors that also promote the growth of small-scale manufacturing, leading to the increasing demand of real-time supply chain.
Not only can Croft offer innovative filtration solutions with over 30 years of experience, but the company can also supply filters in a small number, allowing pharmaceutical manufacturers to carry out small-scale production more effectively. Additionally, we can also deliver products within a short lead time, as little as 2 days, minimising the waiting time for filter parts and the overall R&D process.
The increase in reshoring investment for pharmaceutical companies
Whilst the pandemic has significantly affected the global supply chains, the possible effects of Brexit also influences UK firms to rethink their supply-chain strategies. This results in companies reversing the trend of having global supply network to increasing investment in reshoring.
Based in Warrington, England, Croft can benefit UK pharmaceutical manufacturers with reliable filter supplies and high-quality products made in Britain. Each filter manufactured to high standards and compliances to achieve desired filtering effects.
More integrated equipment in pharma manufacturing
It is said that the pharma companies will continuingly upgrade equipment assets to enhance operational efficiency. This means changing parts whilst integrating them more effectively within the system.
Our ability to manufacturer filter components to suit the exact application and fit in the system helps pharmaceutical manufacturing firms with the developing process of their operating system or equipment.
With the impact of coronavirus hopefully coming to an end soon, Pharmaceutical and all other industries will have to adjust to the new normal. Croft is committed to help manufacturers within all sectors to quickly and smoothly adapt and continue to operate.
We supply pharmaceutical manufacturing companies with screen filters, cone filters and other types of filters to help with the customers’ filtration problems to ensure an uninterrupted and effective production line. From our experience, we understand that precision is important to the manufacturing process within Pharmaceutical sector.
Improving filtration efficiency can be a challenge. Especially for companies that are trying to deliver the highest possible open area across the filter media.